Global Virus Like Particles Market Analysis 2016-2020 and Forecast 2021-2026

Publication Month: Feb 2021 | No. of Pages: 108 Published By: 99Strategy
Single User License: US $ 2980
Corporate User License: US $ 5960

Snapshot

The global Virus Like Particles market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Virus Like Particles by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Adeno-Associated Virus
HIV
Hepatitis B Virus
Hepatitis C Virus
Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
GlaxoSmithKline
Merck
Novavax
Takeda
Medicago
MedImmune
TechnoVax
Agilvax
Allergy Therapeutics
Serum Institute of India
GeoVax Labs
Cytos Biotechnology
ANGANY Genetics
CPL Biologicals
Xiamen Innovax Biotech

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Vaccines
Mycoviruses
Virus Research
Therapeutic and Imaging Agents
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)

Table of Contents
1 Industry Overview
1.1 Virus Like Particles Industry
Figure Virus Like Particles Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Virus Like Particles
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Virus Like Particles
1.2.2 Downstream
Table Application Segment of Virus Like Particles
Table Global Virus Like Particles Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Virus Like Particles Market by Type
3.1 By Type
3.1.1 Adeno-Associated Virus
Table Major Company List of Adeno-Associated Virus
3.1.2 HIV
Table Major Company List of HIV
3.1.3 Hepatitis B Virus
Table Major Company List of Hepatitis B Virus
3.1.4 Hepatitis C Virus
Table Major Company List of Hepatitis C Virus
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global Virus Like Particles Market 2016-2020, by Type, in USD Million
Figure Global Virus Like Particles Market Growth 2016-2020, by Type, in USD Million
Table Global Virus Like Particles Market 2016-2020, by Type, in Volume
Figure Global Virus Like Particles Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Virus Like Particles Market Forecast 2021-2026, by Type, in USD Million
Table Global Virus Like Particles Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 GlaxoSmithKline (Company Profile, Sales Data etc.)
4.1.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
4.1.2 GlaxoSmithKline Products & Services
4.1.3 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Merck (Company Profile, Sales Data etc.)
4.2.1 Merck Profile
Table Merck Overview List
4.2.2 Merck Products & Services
4.2.3 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Novavax (Company Profile, Sales Data etc.)
4.3.1 Novavax Profile
Table Novavax Overview List
4.3.2 Novavax Products & Services
4.3.3 Novavax Business Operation Conditions
Table Business Operation of Novavax (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Takeda (Company Profile, Sales Data etc.)
4.4.1 Takeda Profile
Table Takeda Overview List
4.4.2 Takeda Products & Services
4.4.3 Takeda Business Operation Conditions
Table Business Operation of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Medicago (Company Profile, Sales Data etc.)
4.5.1 Medicago Profile
Table Medicago Overview List
4.5.2 Medicago Products & Services
4.5.3 Medicago Business Operation Conditions
Table Business Operation of Medicago (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 MedImmune (Company Profile, Sales Data etc.)
4.6.1 MedImmune Profile
Table MedImmune Overview List
4.6.2 MedImmune Products & Services
4.6.3 MedImmune Business Operation Conditions
Table Business Operation of MedImmune (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 TechnoVax (Company Profile, Sales Data etc.)
4.7.1 TechnoVax Profile
Table TechnoVax Overview List
4.7.2 TechnoVax Products & Services
4.7.3 TechnoVax Business Operation Conditions
Table Business Operation of TechnoVax (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Agilvax (Company Profile, Sales Data etc.)
4.8.1 Agilvax Profile
Table Agilvax Overview List
4.8.2 Agilvax Products & Services
4.8.3 Agilvax Business Operation Conditions
Table Business Operation of Agilvax (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Allergy Therapeutics (Company Profile, Sales Data etc.)
4.9.1 Allergy Therapeutics Profile
Table Allergy Therapeutics Overview List
4.9.2 Allergy Therapeutics Products & Services
4.9.3 Allergy Therapeutics Business Operation Conditions
Table Business Operation of Allergy Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Serum Institute of India (Company Profile, Sales Data etc.)
4.10.1 Serum Institute of India Profile
Table Serum Institute of India Overview List
4.10.2 Serum Institute of India Products & Services
4.10.3 Serum Institute of India Business Operation Conditions
Table Business Operation of Serum Institute of India (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 GeoVax Labs (Company Profile, Sales Data etc.)
4.11.1 GeoVax Labs Profile
Table GeoVax Labs Overview List
4.11.2 GeoVax Labs Products & Services
4.11.3 GeoVax Labs Business Operation Conditions
Table Business Operation of GeoVax Labs (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Cytos Biotechnology (Company Profile, Sales Data etc.)
4.12.1 Cytos Biotechnology Profile
Table Cytos Biotechnology Overview List
4.12.2 Cytos Biotechnology Products & Services
4.12.3 Cytos Biotechnology Business Operation Conditions
Table Business Operation of Cytos Biotechnology (Sales Revenue, Cost, Gross Margin)
4.13 ANGANY Genetics (Company Profile, Sales Data etc.)
4.13.1 ANGANY Genetics Profile
Table ANGANY Genetics Overview List
4.13.2 ANGANY Genetics Products & Services
4.13.3 ANGANY Genetics Business Operation Conditions
Table Business Operation of ANGANY Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 CPL Biologicals (Company Profile, Sales Data etc.)
4.14.1 CPL Biologicals Profile
Table CPL Biologicals Overview List
4.14.2 CPL Biologicals Products & Services
4.14.3 CPL Biologicals Business Operation Conditions
Table Business Operation of CPL Biologicals (Sales Revenue, Cost, Gross Margin)
4.15 Xiamen Innovax Biotech (Company Profile, Sales Data etc.)
4.15.1 Xiamen Innovax Biotech Profile
Table Xiamen Innovax Biotech Overview List
4.15.2 Xiamen Innovax Biotech Products & Services
4.15.3 Xiamen Innovax Biotech Business Operation Conditions
Table Business Operation of Xiamen Innovax Biotech (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Virus Like Particles Sales Revenue 2016-2020, by Company, in USD Million
Table Global Virus Like Particles Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Virus Like Particles Sales Revenue Share in 2020, by Company, in USD Million
Table Global Virus Like Particles Sales Volume 2016-2020, by Company, in Volume
Table Global Virus Like Particles Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Virus Like Particles Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Virus Like Particles Market Concentration, in 2020
Figure Europe Virus Like Particles Market Market Concentration, in 2020
Figure Asia-Pacific Virus Like Particles MMarket Concentration, in 2020
Figure South America Virus Like Particles Market Concentration, in 2020
Figure Middle East & Africa Virus Like Particles Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Vaccines
Figure Virus Like Particles Demand in Vaccines, 2016-2020, in USD Million
Figure Virus Like Particles Demand in Vaccines, 2016-2020, in Volume
6.1.2 Demand in Mycoviruses
Figure Virus Like Particles Demand in Mycoviruses, 2016-2020, in USD Million
Figure Virus Like Particles Demand in Mycoviruses, 2016-2020, in Volume
6.1.3 Demand in Virus Research
Figure Virus Like Particles Demand in Virus Research, 2016-2020, in USD Million
Figure Virus Like Particles Demand in Virus Research, 2016-2020, in Volume
6.1.4 Demand in Therapeutic and Imaging Agents
Figure Virus Like Particles Demand in Therapeutic and Imaging Agents, 2016-2020, in USD Million
Figure Virus Like Particles Demand in Therapeutic and Imaging Agents, 2016-2020, in Volume
6.1.5 Demand in Others
Figure Virus Like Particles Demand in Others, 2016-2020, in USD Million
Figure Virus Like Particles Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Virus Like Particles Demand Forecast 2021-2026, by Application, in USD Million
Figure Virus Like Particles Market Growth 2021-2026, by Application, in USD Million
Figure Virus Like Particles Market Share in 2026, by Application, in USD Million
Table Virus Like Particles Demand Forecast 2021-2026, by Application, in Volume
Table Virus Like Particles Market Growth 2021-2026, by Application, in Volume
Table Virus Like Particles Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Virus Like Particles Production 2016-2020, by Region, in USD Million
Table Virus Like Particles Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Virus Like Particles Market 2016-2020, by Region, in USD Million
Table Global Virus Like Particles Market Share 2016-2020, by Region, in USD Million
Table Global Virus Like Particles Market 2016-2020, by Region, in Volume
Table Global Virus Like Particles Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Virus Like Particles Market Size and Growth 2016-2020, in USD Million
Figure North America Virus Like Particles Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Virus Like Particles Market Size 2016-2020, by Country, in USD Million
Table North America Virus Like Particles Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Virus Like Particles Market Size and Growth 2016-2020, in USD Million
Figure Europe Virus Like Particles Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Virus Like Particles Market Size 2016-2020, by Country, in USD Million
Table Europe Virus Like Particles Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Virus Like Particles Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Virus Like Particles Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Virus Like Particles Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Virus Like Particles Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Virus Like Particles Market Size and Growth 2016-2020, in USD Million
Figure South America Virus Like Particles Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Virus Like Particles Market Size 2016-2020, by Country, in USD Million
Table South America Virus Like Particles Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Virus Like Particles Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Virus Like Particles Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Virus Like Particles Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Virus Like Particles Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Virus Like Particles Market Forecast 2021-2026, by Region, in USD Million
Table Virus Like Particles Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

Tables and Figures

List of Table
1. Table Upstream Segment of Virus Like Particles
2. Table Application Segment of Virus Like Particles
3. Table Global Virus Like Particles Market 2016-2026, by Application, in USD Million
4. Table Major Company List of HIV
5. Table Major Company List of Hepatitis B Virus
6. Table Major Company List of Hepatitis C Virus
7. Table Major Company List of Others
8. Table Global Virus Like Particles Market 2016-2020, by Type, in USD Million
9. Table Global Virus Like Particles Market 2016-2020, by Type, in Volume
10. Table Global Virus Like Particles Market Forecast 2021-2026, by Type, in USD Million
11. Table Global Virus Like Particles Market Forecast 2021-2026, by Type, in Volume
12. Table GlaxoSmithKline Overview List
13. Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table Merck Overview List
15. Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Novavax Overview List
17. Table Business Operation of Novavax (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Takeda Overview List
19. Table Business Operation of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Medicago Overview List
21. Table Business Operation of Medicago (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table MedImmune Overview List
23. Table Business Operation of MedImmune (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table TechnoVax Overview List
25. Table Business Operation of TechnoVax (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Agilvax Overview List
27. Table Business Operation of Agilvax (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table Allergy Therapeutics Overview List
29. Table Business Operation of Allergy Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
30. Table Serum Institute of India Overview List
31. Table Business Operation of Serum Institute of India (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
32. Table GeoVax Labs Overview List
33. Table Business Operation of GeoVax Labs (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
34. Table Cytos Biotechnology Overview List
35. Table Business Operation of Cytos Biotechnology (Sales Revenue, Cost, Gross Margin)
36. Table ANGANY Genetics Overview List
37. Table Business Operation of ANGANY Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
38. Table CPL Biologicals Overview List
39. Table Business Operation of CPL Biologicals (Sales Revenue, Cost, Gross Margin)
40. Table Xiamen Innovax Biotech Overview List
41. Table Business Operation of Xiamen Innovax Biotech (Sales Revenue, Cost, Gross Margin)
42. Table Global Virus Like Particles Sales Revenue 2016-2020, by Company, in USD Million
43. Table Global Virus Like Particles Sales Revenue Share 2016-2020, by Company, in USD Million
44. Table Global Virus Like Particles Sales Volume 2016-2020, by Company, in Volume
45. Table Global Virus Like Particles Sales Volume Share 2016-2020, by Company, in Volume
46. Table Regional Demand Comparison List
47. Table Major Application in Different Regions
48. Table Virus Like Particles Demand Forecast 2021-2026, by Application, in USD Million
49. Table Virus Like Particles Demand Forecast 2021-2026, by Application, in Volume
50. Table Virus Like Particles Market Growth 2021-2026, by Application, in Volume
51. Table Virus Like Particles Market Share in 2026, by Application, in Volume
52. Table Virus Like Particles Production 2016-2020, by Region, in USD Million
53. Table Virus Like Particles Production 2016-2020, by Region, in Volume
54. Table Global Virus Like Particles Market 2016-2020, by Region, in USD Million
55. Table Global Virus Like Particles Market Share 2016-2020, by Region, in USD Million
56. Table Global Virus Like Particles Market 2016-2020, by Region, in Volume
57. Table Global Virus Like Particles Market Share 2016-2020, by Region, in Volume
58. Table North America Virus Like Particles Market Size 2016-2020, by Country, in USD Million
59. Table North America Virus Like Particles Market Size 2016-2020, by Country, in Volume
60. Table Europe Virus Like Particles Market Size 2016-2020, by Country, in USD Million
61. Table Europe Virus Like Particles Market Size 2016-2020, by Country, in Volume
62. Table Asia-Pacific Virus Like Particles Market Size 2016-2020, by Country, in USD Million
63. Table Asia-Pacific Virus Like Particles Market Size 2016-2020, by Country, in Volume
64. Table South America Virus Like Particles Market Size 2016-2020, by Country, in USD Million
65. Table South America Virus Like Particles Market Size 2016-2020, by Country, in Volume
66. Table Middle East & Africa Virus Like Particles Market Size 2016-2020, by Country, in USD Million
67. Table Middle East & Africa Virus Like Particles Market Size 2016-2020, by Country, in Volume
68. Table Virus Like Particles Market Forecast 2021-2026, by Region, in USD Million
69. Table Virus Like Particles Market Forecast 2021-2026, by Region, in Volume
70. Table Price Factors List



List Of Figures
List of Figure
1. Figure Virus Like Particles Industry Chain Structure
2. Figure Global Virus Like Particles Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Virus Like Particles Market Growth 2016-2020, by Type, in Volume
4. Figure Global Virus Like Particles Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Virus Like Particles Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Virus Like Particles Market Concentration, in 2020
7. Figure Europe Virus Like Particles Market Market Concentration, in 2020
8. Figure Asia-Pacific Virus Like Particles MMarket Concentration, in 2020
9. Figure South America Virus Like Particles Market Concentration, in 2020
10. Figure Middle East & Africa Virus Like Particles Market Concentration, in 2020
11. Figure Virus Like Particles Demand in Vaccines, 2016-2020, in USD Million
12. Figure Virus Like Particles Demand in Vaccines, 2016-2020, in Volume
13. Figure Virus Like Particles Demand in Mycoviruses, 2016-2020, in USD Million
14. Figure Virus Like Particles Demand in Mycoviruses, 2016-2020, in Volume
15. Figure Virus Like Particles Demand in Virus Research, 2016-2020, in USD Million
16. Figure Virus Like Particles Demand in Virus Research, 2016-2020, in Volume
17. Figure Virus Like Particles Demand in Therapeutic and Imaging Agents, 2016-2020, in USD Million
18. Figure Virus Like Particles Demand in Therapeutic and Imaging Agents, 2016-2020, in Volume
19. Figure Virus Like Particles Demand in Others, 2016-2020, in USD Million
20. Figure Virus Like Particles Demand in Others, 2016-2020, in Volume
21. Figure Virus Like Particles Market Growth 2021-2026, by Application, in USD Million
22. Figure Virus Like Particles Market Share in 2026, by Application, in USD Million
23. Figure North America Virus Like Particles Market Size and Growth 2016-2020, in USD Million
24. Figure North America Virus Like Particles Market Size and Growth 2016-2020, in Volume
25. Figure Europe Virus Like Particles Market Size and Growth 2016-2020, in USD Million
26. Figure Europe Virus Like Particles Market Size and Growth 2016-2020, in Volume
27. Figure Asia-Pacific Virus Like Particles Market Size and Growth 2016-2020, in USD Million
28. Figure Asia-Pacific Virus Like Particles Market Size and Growth 2016-2020, in Volume
29. Figure South America Virus Like Particles Market Size and Growth 2016-2020, in USD Million
30. Figure South America Virus Like Particles Market Size and Growth 2016-2020, in Volume
31. Figure Middle East & Africa Virus Like Particles Market Size and Growth 2016-2020, in USD Million
32. Figure Middle East & Africa Virus Like Particles Market Size and Growth 2016-2020, in Volume
33. Figure Marketing Channels Overview

Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets